Add like
Add dislike
Add to saved papers

Polycyclic aromatic hydrocarbons in urban soil of Novi Sad, Serbia: occurrence and cancer risk assessment.

Contents of 16 polycyclic aromatic hydrocarbons were analyzed in 30 soil samples from 15 locations in Novi Sad, Serbia, assessing for the first time the corresponding health risks in the Serbian urban zone. Total concentrations were in the range of 22-2247 μg kg-1 , with a mean and median value of 363 and 200 μg kg-1 , respectively. Comparison with the relevant maximum allowed contents proposed by the Serbian government and with the Dutch target values implied that soils from the urban area of Novi Sad were "suitable as residential soils" and that no intervention would be needed if the current levels were retained. Seven diagnostic ratios were calculated, indicating the pyrogenic sources of PAHs as the dominant. Cancer risks in humans via accidental ingestion, inhalation of soil particles, and dermal contact with soil were estimated. Cancer risk for soil ingestion by children was the highest. The total lifetime carcinogenic risk as sum of individual cancer risks for seven carcinogenic polycyclic aromatic hydrocarbons was within the range 10-4 to 10-6 , indicating acceptable risks at 30 and 47% of sites for children and adults, respectively. However, for the rest of the samples, total lifetime cancer risk was >10-4 indicating over the acceptable risk, even though the contents in soil were not of concern as the comparison with the environmental guidance previously showed. This could be explained by (a) the dominant concentrations of higher molecular weight compounds with 4 to 6 rings, among which there are compounds with higher toxicity equivalents, but also with (b) the extreme conditions used for the conservative risk assessment under maximal exposure frequency, exposure time, and ingestion rates.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app